Climax Shield Delay

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Climax Shield Delay
Generic name: BENZOCAINE
Manufacturer: PRODUCT MAX GROUP INC
Product type: HUMAN OTC DRUG
SPL set ID: 9c720cdc-f753-47ce-95ff-3b26e461a0ab
SPL ID: 3462baa1-0c26-bebc-e063-6294a90a81cb
Version: 1
Effective date: 2025-05-05
Source export date: 2026-10-12
Source partition: 11
Source file: https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/a497e765d824a2e2aa9e88d5f0eea2aae9dcba363989e5f163395cda5c3c9dd8/drug-label-0011-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 02:45:35

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 10 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		Climax Shield Delay	openfda.brand_name
generic name		BENZOCAINE	openfda.generic_name
manufacturer name		PRODUCT MAX GROUP INC	openfda.manufacturer_name
ndc	package	70742-598-00	openfda.package_ndc
ndc	product	70742-598	openfda.product_ndc
ndc11	package	70742059800	derived:openfda.package_ndc
spl id		3462baa1-0c26-bebc-e063-6294a90a81cb	id
spl set id		9c720cdc-f753-47ce-95ff-3b26e461a0ab	set_id
unii		U3RSY48JW5	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. Premature ejaculation may be due to a condition requiring medical supervision. If this product, used as directed, does not provide relief, discontinue use and consult a doctor. Avoid contact with the eyes. If you or your partner develop a rash or irritation, such as burning or itching, discontinue use. If symptoms persist, consult a doctor. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.